Pfizer Logo
US7170811035
852009
PFE

Pfizer

Caricamento quotazioni...

Previsioni

Il prezzo obiettivo medio degli analisti è 24,61 € (+2,76%). La mediana è 23,56 € (-1,63%).

Acquista
  15
Mantieni
  23
Vendi
  1

  • Pfizer Lyme vaccine application enters EMA review despite Phase 3 statistical caveat

    The EMA has validated the marketing application for PF-07307405, the Pfizer–Valneva Lyme vaccine, and begun formal review. The submission is based on the Phase 3 VALOR trial showing >70% efficacy and no safety signals, but the primary prespecified analysis missed its predefined statistical confidence-bound threshold while a second analysis met it. Approval would leave the partners with little direct competition in Europe, but review timelines, pricing and commercialization details remain uncertain and the market reaction was muted. » Altro su finance.yahoo.com


  • Pfizer's 6% dividend looks secure but rests on thin cash flow and heavy debt

    Pfizer pays a 6.19% yield that is currently covered by free cash flow, and management has explicitly committed to maintain the payout. COVID-era revenues from Comirnaty and Paxlovid have plunged 59% and 63%, and newly launched products are growing but not yet fully replacing lost sales. The company carries $60.5 billion of long-term debt versus $976 million in cash, and the $2.45 billion quarterly dividend competes directly with debt service; a sustained drop in operating cash flow below the dividend for two quarters would threaten the payout. » Altro su finance.yahoo.com


  • Pfizer's dividend likely sustainable despite payout ratio above 100%

    Pfizer's dividend appears maintainable because cash flow covers roughly 90% of payouts and the company held about $12.7 billion in cash and short-term investments at end of Q2 2026, enough to fund more than a year of dividend payments. Management has publicly stated it intends to keep the dividend, reducing near-term cut risk. The main concern is revenue pressure from patent expirations and a pipeline shortfall; a dividend cut remains possible in a severe downside but even a large reduction would leave a yield above market levels. » Altro su finance.yahoo.com

Nel 2026, Pfizer ha già distribuito 1,11 € di dividendi. L'ultimo pagamento è avvenuto a settembre.

Dati finanziari dell'azienda

Nell'ultimo trimestre, Pfizer ha registrato ricavi pari a 13,2 Mld € e un utile netto di -216,05 Mln €
(EUR) giugno 2026
YoY
Ricavi 13,2 Mld 5,67%
Utile lordo 9,61 Mld 19,63%
Utile netto -216,05 Mln 108,71%
EBITDA 1,05 Mld 76,80%

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
137,02 Mld €
Numero di azioni
5,7 Mld
Massimo/minimo a 52 settimane
25,49 € - 20,58 €
Rendimento da dividendo
6,19%
Dividendi TTM
1,48 €
Beta
0,30
Rapporto P/E
36,40
Rapporto PEG
-0,61
Rapporto P/B
1,84
Rapporto P/S
2,47

Profilo aziendale

Pfizer Inc. erforscht, entwickelt, produziert, vermarktet, vertreibt und verkauft weltweit biopharmazeutische Produkte. Das Unternehmen bietet Medikamente und Impfstoffe in verschiedenen therapeutischen Bereichen an, darunter Herz-Kreislauf-Stoffwechsel- und Frauengesundheit unter den Marken Premarin und Eliquis; Biologika, kleine Moleküle, Immuntherapien und Biosimilars unter den Marken Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena und Braftovi; und sterile injizierbare und antiinfektiöse Arzneimittel sowie orale COVID-19-Behandlung unter den Marken Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga und Paxlovid. Das Unternehmen bietet auch Arzneimittel und Impfstoffe in verschiedenen therapeutischen Bereichen an, wie Pneumokokken, Meningokokken, Zeckenenzephalitis und COVID-19 unter den Marken Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba und der Prevnar-Familie; Biosimilars für chronische Immun- und Entzündungskrankheiten unter den Marken Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis und Cibinqo sowie Amyloidose, Hämophilie und endokrine Erkrankungen unter den Marken Vyndaqel/Vyndamax, BeneFIX und Genotropin. Darüber hinaus ist das Unternehmen im Bereich der Auftragsherstellung tätig. Das Unternehmen beliefert Großhändler, Einzelhändler, Krankenhäuser, Kliniken, Behörden, Apotheken und einzelne Anbieter sowie Zentren für Krankheitskontrolle und Prävention. Das Unternehmen hat Kooperationsvereinbarungen mit Bristol-Myers Squibb Company, Astellas Pharma US, Inc, Myovant Sciences Ltd, Akcea Therapeutics, Inc, Merck KGaA, Valneva SE, BioNTech SE und Arvinas, Inc. Pfizer Inc. wurde 1849 gegründet und hat seinen Hauptsitz in New York, New York.

Nome
Pfizer
CEO
Albert Bourla
Sede centrale New York City, ny
Stati Uniti
Sito web
Settore
Sanità
Industria
Prodotti farmaceutici
Quotazione in borsa
26/02/2021
Dipendenti 75.000

Simboli di borsa

Borsa Simbolo
NYSE
PFE
XETRA
PFE.DE
XETRA
PFE.F
Frankfurt
PFE.F
Düsseldorf
PFE.DU
Hamburg
PFE.HM
Milan
1PFE.MI
London
0Q1N.L
SIX
PFE.SW
München
PFE.MU
Wien
PFE.VI
🍪

Parqet  usa i cookie. Scopri di più